True Wealth Design’s Keros Therapeutics KROS Stock Holding History

True Wealth Design’s Portfolio KROS Stock Details KROS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.7K	Sell	149 -11	-7%	-$120	﹤0.01%	1736
2026 Q2	$1.71K	Buy	160 +145	+967%	+$1.61K	﹤0.01%	1754
2026 Q1	$166	Sell	15 -57	-79%	-$880	﹤0.01%	2368
2025 Q4	$1.47K	Buy	72 +53	+279%	+$930	﹤0.01%	1567
2025 Q3	$301	Buy	19 +13	+217%	+$192	﹤0.01%	2184
2025 Q2	$81	Buy	6 +3	+100%	+$41	﹤0.01%	2291
2025 Q1	$31	Buy	+3	New	+$35	﹤0.01%	2503

Other funds holding KROS

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

True Wealth Design's KROS Position: Q3 2026 in Review

True Wealth Design reduced its Keros Therapeutics (KROS) stake by 6.9% in Q3 2026, selling an estimated $120 and leaving 149 shares worth $1.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1736.

True Wealth Design first reported a position in KROS in Q1 2025 and has held it in 7 quarters since. The position peaked at $1.71K in Q2 2026. 6 funds tracked by Wall St. Rank hold KROS as of Q3 2026.

True Wealth Design held 149 shares of Keros Therapeutics worth $1.7K as of Q3 2026.
True Wealth Design sold 11 Keros Therapeutics shares in Q3 2026, an estimated $120.
Keros Therapeutics made up ﹤0.01% of True Wealth Design's portfolio in Q3 2026, its #1736 holding.
True Wealth Design first reported a position in Keros Therapeutics in Q1 2025 and has held it in 7 quarters since.
True Wealth Design's Keros Therapeutics position peaked at $1.71K in Q2 2026.
6 funds tracked by Wall St. Rank held Keros Therapeutics as of Q3 2026.

Based on True Wealth Design's 13F filing for Q3 2026, filed 13 Oct 2026.